Filters: Author is Grandori, Carla [Clear All Filters]
PPP2R2C loss promotes castration-resistant prostate cancer growth and is associated with increased prostate cancer-specific mortality.. Molecular cancer research : MCR. 11(6):568-578.. 2013.
Synthetic Lethal Screens as a Means to Understand and Treat MYC-Driven Cancers.. Cold Spring Harbor perspectives in medicine. 4(3). 2014.
Functional genomics to identify unforeseen cancer drug targets.. Future oncology (London, England). 9(4):473-6.. 2013.
Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.. Cancer science. 106(4):421-9.. 2015.
MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.. Molecular cancer research : MCR. 10(4):535-45.. 2012.
c-Myc accelerates S-Phase and requires WRN to avoid replication stress.. PloS one. 4(6):e5951.. 2009.
Functional genomics identifies therapeutic targets for MYC-driven cancer.. Proceedings of the National Academy of Sciences of the United States of America. 109(24):9545-50.. 2012.
The Role and Efficacy of Retinoic Acid (Ra) and the Flt3 Inhibitor as Combination Therapy for High Risk Neuroblastoma. Pediatric Blood & Cancer. 61:S96-S96.. 2014.
Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβ.. Cell cycle (Georgetown, Tex.). 10(15):2540-8.. 2011.
NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.. Journal of virology. 84(21):11461-9.. 2010.
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.. Molecular and cellular biology. 28(15):4819-28.. 2008.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Journals List
- Ovid (guest or library account)
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog (Account Login)
- Document Delivery Form
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Authored Papers (Intranet)